132 related articles for article (PubMed ID: 29426626)
1. Antituberculosis Treatment in a Patient with Celiac Disease.
Cerezo Lajas A; Caminero Luna JA; Rodríguez Guzmán MDC; de Miguel Díez J
Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):337-338. PubMed ID: 29426626
[No Abstract] [Full Text] [Related]
2. Antituberculosis agents.
Goldberger MJ
Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
[TBL] [Abstract][Full Text] [Related]
3. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Gillespie SH; Crook AM; McHugh TD; Mendel CM; Meredith SK; Murray SR; Pappas F; Phillips PP; Nunn AJ;
N Engl J Med; 2014 Oct; 371(17):1577-87. PubMed ID: 25196020
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of tuberculosis for patients with renal impairment.
Ellard GA
Nephron; 1993; 64(2):169-81. PubMed ID: 8321347
[No Abstract] [Full Text] [Related]
5. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
Mofredj A; Guérin JM; Leibinger F; Masmoudi R
Infection; 1996; 24(5):390-1. PubMed ID: 8923052
[No Abstract] [Full Text] [Related]
7. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
[No Abstract] [Full Text] [Related]
8. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in antituberculosis chemotherapy.
Chan SL
Xianggang Hu Li Za Zhi; 1979 Nov; (27):19-27. PubMed ID: 317480
[No Abstract] [Full Text] [Related]
10. Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
Asano T; Kawamoto H; Asakuma J; Tanimoto T; Kobayashi H; Hayakawa M
Transplant Proc; 2000 Nov; 32(7):1960-2. PubMed ID: 11120020
[No Abstract] [Full Text] [Related]
11. The impact of chemotherapy on the care of patients with tuberculosis.
Johnston RF; Wildrick KH
Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115
[No Abstract] [Full Text] [Related]
12. [Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Soto-Cabrera E; Villamil-Osorio LV; Garcia-Luna RC; Carrera-Pineda R
Rev Neurol; 2018 Apr; 66(8):286-288. PubMed ID: 29645073
[TBL] [Abstract][Full Text] [Related]
13. [Myrin P in the combined treatment of tuberculosis].
Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
[TBL] [Abstract][Full Text] [Related]
14. The action of antituberculosis drugs in short-course chemotherapy.
Mitchison DA
Tubercle; 1985 Sep; 66(3):219-25. PubMed ID: 3931319
[No Abstract] [Full Text] [Related]
15. [Principles underlying the use of antituberculosis medication in children (author's transl)].
Ollivier A; Besson-Leaud M
Sem Hop; 1979 Oct 8-15; 55(33-34):1529-35. PubMed ID: 229564
[TBL] [Abstract][Full Text] [Related]
16. Treatment of tuberculosis. The Mitchell lecture 1979.
Mitchison DA
J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
[No Abstract] [Full Text] [Related]
17. Individualising therapy for drug-sensitive tuberculosis.
Esmail H; Lipman MC; Nunn A; Walker TM
Lancet Respir Med; 2019 Oct; 7(10):834-835. PubMed ID: 31427253
[No Abstract] [Full Text] [Related]
18. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
[No Abstract] [Full Text] [Related]
19. Present status of chemotherapy for tuberculosis.
Grosset JH
Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
[TBL] [Abstract][Full Text] [Related]
20. Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.
Carr W; Kurbatova E; Starks A; Goswami N; Allen L; Winston C
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(8):285-289. PubMed ID: 35202353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
